Adamas Pharmaceuticals CEO Neil McFarlane's 2020 pay slips 19% to $1.7M
Adamas Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 19, 2021
Adamas Pharmaceuticals reported fiscal year 2020 executive compensation information on April 19, 2021.
In 2020, three executives at Adamas Pharmaceuticals received on average a compensation package of $1.1M, a 41% decrease compared to previous year.
Average pay of disclosed executives at Adamas Pharmaceuticals
Neil F. McFarlane, Chief Executive Officer, received $1.7M in total, which decreased by 19% compared to 2019. 36% of McFarlane's compensation, or $604K, was in salary. McFarlane also received $31K in bonus, $431K in non-equity incentive plan, $233K in option awards, $199K in stock awards, as well as $194K in other compensation.
Vijay Shreedhar, Chief Commercial Officer, received a compensation package of $842K, which decreased by 32% compared to previous year. 50% of the compensation package, or $418K, was in salary.
Christopher B. Prentiss, Chief Financial Officer, earned $621K in 2020, a 43% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 19, 2021.